The Global Risks Report 2016 is on line
The Global Risks Report 2016 features perspectives from nearly 750 experts on the perceived impact and likelihood of 29 prevalent global risks over a 10-year timeframe. The risks are divided into five categories: economic, environmental, geopolitical, societal and technological.
The report also examines the interconnections among the risks, and through that analysis explores three areas where global risks have the greatest potential to impact society. These are the concept of the “(dis)empowered citizen”, the impact of climate change on food security, and the potential of pandemics to threaten social cohesion.
The report also takes an in-depth look at the how the global security landscape could evolve in the future; sharing the outcomes of a year-long study to examine current trends and possible driving forces for the future of international security.
The report gave rise to a conference
Speakers:
- Adrian Monck, Head of Public Engagement and Foundations, World Economic Forum (moderator)
- Margareta Drzeniek Hanouz, Head of Global Competitiveness and Risks, World Economic Forum
- John Drzik, President, Global Risk and Specialties, Marsh
- Espen Barth Eide, Head of Geopolitical Affairs, World Economic Forum
- Cecilia Reyes, Chief Risk Officer, Zurich Insurance Group
Related Articles
UN aid officials urge Security Council to push for greater humanitarian access in Syria
01/26/2017. “We need to be allowed to pass – not as a favour but as a right – and safely.” he said.
Aleppo: ICRC calls to stop violence
04/29/2016. “There is no safe place anymore in Aleppo. Even in hospitals,” Marianne Gasser, head of the ICRC in Syria.
Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
